Have a personal or library account? Click to login
Immunotherapeutic efficacy of a Lactobacillus casei lysate as an adjuvant combined with a heated-4T1 mammary carcinoma cell lysate in a murine model of breast cancer Cover

Immunotherapeutic efficacy of a Lactobacillus casei lysate as an adjuvant combined with a heated-4T1 mammary carcinoma cell lysate in a murine model of breast cancer

Asian Biomedicine
Volume 10 (2016): Issue 4 (August 2016)
By: Ruhollah Dorostkar,  Mohammad Sadegh Hashemzadeh,  Sajjad Jafari,  Mahdi Tat,  Majdedin Ghalavand,  Mohammad Hossein Asghari and  Milad Moloudizargari  
Open Access
|Jan 2017

References

  1. 1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65:5-29.10.3322/caac.2125425559415
    SiegelRLMillerKDJemalACancer statistics 2015CA Cancer J Clin20156552925559415
    Open DOIBack to article
  2. 2DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014; 64:52-62.2411456810.3322/caac.21203
    DeSantisCMaJBryanLJemalABreast cancer statistics 2013CA Cancer J Clin201464526224114568
    Open DOIBack to article
  3. 3Howard-Anderson J, Ganz PA, Bower JE, Stanton AL. Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. J Natl Cancer Inst. 2012; 104: 386-405.10.1093/jnci/djr54122271773
    Howard-AndersonJGanzPABowerJEStantonALQuality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic reviewJ Natl Cancer Inst201210438640522271773
    Open DOIBack to article
  4. 4Finn OJ. Cancer immunology. New Engl J Med. 2008; 358:2704-15.10.1056/NEJMra072739
    FinnOJCancer immunologyNew Engl J Med200835827041518565863
    Open DOIBack to article
  5. 5Dougan M, Dranoff G. Immunotherapy of cancer. In: Wang R-F, editor. Innate immune regulation and cancer immunotherapy. New York: Springer; 2012. p. 391-414.
    DouganMDranoffGImmunotherapy of cancerWangR-FInnate immune regulation and cancer immunotherapyNew YorkSpringer201239141410.1007/978-1-4419-9914-6_22
    Back to article
  6. 6Dougan M, Dranoff G. Immune therapy for cancer. Annu Rev Immunol. 2009; 27:83-117.10.1146/annurev.immunol.021908.13254419007331
    DouganMDranoffGImmune therapy for cancerAnnu Rev Immunol2009278311719007331
    Open DOIBack to article
  7. 7Mueller M, Reichardt W, Koerner J, Groettrup M. Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice. J Controlled Release. 2012; 162:159-66.10.1016/j.jconrel.2012.06.015
    MuellerMReichardtWKoernerJGroettrupMCoencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP miceJ Controlled Release20121621596622709589
    Open DOIBack to article
  8. 8González FE, Gleisner A, Falcόn-Beas F, Osorio F, Lόpez MN, Salazar-Onfray F. Tumor cell lysates as immunogenic sources for cancer vaccine design. Hum Vaccin Immunother. 2014; 10:3261-9.10.4161/21645515.2014.98299625625929
    GonzálezFEGleisnerAFalcόnBeasFOsorioFLόpezMNSalazar-OnfrayFTumor cell lysates as immunogenic sources for cancer vaccine designHum Vaccin Immunother20141032619451408925625929
    Open DOIBack to article
  9. 9Chiang CL-L, Coukos G, Kandalaft LE. Whole tumor antigen vaccines: where are we? Vaccines. 2015; 3: 344-72.10.3390/vaccines302034426343191
    ChiangCL-LCoukosGKandalaftLEWhole tumor antigen vaccines:where are we?Vaccines2015334472449435626343191
    Open DOIBack to article
  10. 10Guo QT, Li X, Yang Y, Wei J, Zhao Q, Luo FR, et al. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly (L-lactide) grafted polyethylenimine cationic nanoparticles. J Biomed Nanotechnol. 2014; 10:227-37.2473833110.1166/jbn.2014.1785
    GuoQTLiXYangYWeiJZhaoQLuoFRet alEnhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly (L-lactide) grafted polyethylenimine cationic nanoparticlesJ Biomed Nanotechnol2014102273724738331
    Open DOIBack to article
  11. 11Motlagh BM, Ahangaran NA, Froushani SMA. Calcitriol modulates the effects of bone marrow-derived mesenchymal stem cells on macrophage functions. Iran J Basic Med Sci. 2015; 18:672-76.26351558
    MotlaghBMAhangaranNAFroushaniSMACalcitriol modulates the effects of bone marrow-derived mesenchymal stem cells on macrophage functionsIran J Basic Med Sci20151867276
    Back to article
  12. 12Gill H, Prasad J. Probiotics, immunomodulation, and health benefits. In: Böze Z, editor. Bioactive components of milk. Adv Exp Med Biol vol. 606. New York: Springer; 2008. p. 423-54.10.1007/978-0-387-74087-4_17
    GillHPrasadJProbiotics, immunomodulation, and health benefitsBöszeZBioactive components of milk. Adv Exp Med Biol606New YorkSpringer200842354
    Open DOIBack to article
  13. 13Dong H, Rowland I, Thomas LV, Yaqoob P. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur J Clin Nutr. 2013; 52:1853-63.10.1007/s00394-012-0487-1
    DongHRowlandIThomasLVYaqoobPImmunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteersEur J Clin Nutr201352185363
    Open DOIBack to article
  14. 14Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int J Food Microbiol. 1998; 41:133-40.10.1016/S0168-1605(98)00046-49704862
    MatsuzakiTImmunomodulation by treatment with Lactobacillus casei strain ShirotaInt J Food Microbiol19984113340
    Open DOIBack to article
  15. 15Hwang JW, Baek Y-M, Yang KE, Yoo H-S, Cho C-K, Lee Y-W, et al. Lactobacillus casei extract induces apoptosis in gastric cancer by inhibiting NF-kB and mTOR-mediated signaling. Integr Cancer Ther. 2013; 12:165-73.2250559510.1177/1534735412442380
    HwangJWBaekY-MYangKEYooH-SChoC-KLeeY-Wet alLactobacillus casei extract induces apoptosis in gastric cancer by inhibiting NF-kB and mTOR-mediated signalingIntegr Cancer Ther2013121657322505595
    Open DOIBack to article
  16. 16Kim S-N, Lee WM, Park KS, Kim JB, Han DJ, Bae J. The effect of Lactobacillus casei extract on cervical cancer cell lines. Contemp Oncol (Pozn). 2015; 19: 306-12.26557779
    KimS-NLeeWMParkKSKimJBHanDJBaeJThe effect of Lactobacillus casei extract on cervical cancer cell linesContemp Oncol (Pozn)2015193061210.5114/wo.2014.45292463129626557779
    Back to article
  17. 17Huang Q, Hu JK, Lohr F, Zhang L, Braun R, Lanzen J, et al. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res. 2000; 60:3435-9.10910053
    HuangQHuJKLohrFZhangLBraunRLanzenJet alHeat-induced gene expression as a novel targeted cancer gene therapy strategyCancer Res20006034359
    Back to article
  18. 18Steinman L, Zamvil SS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol. 2006; 60:12-21.10.1002/ana.2091316802293
    SteinmanLZamvilSSHow to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosisAnn Neurol200660122116802293
    Open DOIBack to article
  19. 19Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro. Cell Immunol. 2009; 257:23-31.10.1016/j.cellimm.2009.02.002
    DelirezhNMoazzeniSMShokriFShokrgozarMAAtriMKokhaeiPAutologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitroCell Immunol2009257233119306994
    Open DOIBack to article
  20. 20Lebendiker M. The Wolfson Centre for Applied Structural Biology. Bacterial protein extraction - mini scale - Sonication. 2002. Available at http://wolfson.huji.ac.il/purification/TagProteinPurif/Lysis_Bacterial_Cells.html Accessed March 15, 2016.
    LebendikerMThe Wolfson Centre for Applied Structural BiologyBacterial protein extraction - mini scale - Sonication2002Available athttp://wolfson.huji.ac.il/purification/TagProteinPurif/Lysis_Bacterial_Cells.htmlMarch152016
    Back to article
  21. 21Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol Invest. 2014; 43:54-68.10.3109/08820139.2013.82526924063549
    Abtahi FroushaniSMDelirezhNHobbenaghiRMosayebiGSynergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosisImmunol Invest201443546824063549
    Open DOIBack to article
  22. 22Jahangiri S, Abtahi Froushani SM, Delirezh N. Combination immunotherapy with extract of heated 4T1 and naloxone in mouse model of breast cancer. Turk J Med Sci. 2016; 46:518-23.10.3906/sag-1410-6127511520
    JahangiriSAbtahi FroushaniSMDelirezhNCombination immunotherapy with extract of heated 4T1 and naloxone in mouse model of breast cancerTurk J Med Sci2016465182327511520
    Open DOIBack to article
  23. 23Bausero MA, Page DT, Osinaga E, Asea A. Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumor Biol. 2004; 25: 243-51.10.1159/000081387
    BauseroMAPageDTOsinagaEAseaASurface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasisTumor Biol20042524351176448915627887
    Open DOIBack to article
  24. 24Vanbuskirk A, Crump BL, Margoliash E, Pierce S. A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family. J Exp Med. 1989; 170:1799-809.10.1084/jem.170.6.17992584924
    VanbuskirkACrumpBLMargoliashEPierceSA peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock familyJ Exp Med1989170179980921895242584924
    Open DOIBack to article
  25. 25Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. 2015; 16: 343-53.2578968410.1038/ni.3123
    IwasakiAMedzhitovRControl of adaptive immunity by the innate immune systemNat Immunol20151634353450749825789684
    Open DOIBack to article
  26. 26Tanimura N, Miyake K. Toll like receptors. In: Taniguchi N et al., editors. Glycoscience: biology and medicine. Tokyo: Springer; 2015. p. 707-12.
    TanimuraNMiyakeKToll like receptorsTaniguchiNet al Glycoscience:biology and medicineTokyoSpringer20157071210.1007/978-4-431-54841-6_142
    Back to article
  27. 27Mesa C, Fernández LE. Challenges facing adjuvants for cancer immunotherapy. Immunol Cell Biol. 2004; 82:644-50.10.1111/j.0818-9641.2004.01279.x15550123
    MesaCFernándezLEChallenges facing adjuvants for cancer immunotherapyImmunol Cell Biol2004826445015550123
    Open DOIBack to article
  28. 28Dredge K, Marriott JB, Todryk SM, Dalgleish AG. Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy. Cancer Immunol Immunother. 2002; 51:521-31.10.1007/s00262-002-0309-z12384803
    DredgeKMarriottJBTodrykSMDalgleishAGAdjuvants and the promotion of Th1-type cytokines in tumour immunotherapyCancer Immunol Immunother2002515213112384803
    Open DOIBack to article
  29. 29Bobanga ID, Petrosiute A, Huang AY. Chemokines as cancer vaccine adjuvants. Vaccines. 2013; 1:444-62.2496709410.3390/vaccines1040444
    BobangaIDPetrosiuteAHuangAYChemokines as cancer vaccine adjuvantsVaccines2013144462406704424967094
    Open DOIBack to article
  30. 30Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines. 2011; 10:499-511.2150664710.1586/erv.10.174
    BodeCZhaoGSteinhagenFKinjoTKlinmanDMCpG DNA as a vaccine adjuvantExpert Rev Vaccines201110499511310843421506647
    Open DOIBack to article
  31. 31Lenoir M, del Carmen S, Cortes-Perez NG, Lozano-Ojalvo D, Muñoz-Provencio D, Chain F, et al. Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. J Gastroenterol. 2016:1-12.
    LenoirMdel CarmenSCortes-PerezNGLozano-OjalvoDMuñoz-ProvencioDChainFet alLactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancerJ Gastroenterol201611210.1007/s00535-015-1158-926749362
    Back to article
  32. 32Kaga C, Takagi A, Kano M, Kado S, Kato I, Sakai M, et al. Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer. Cancer Sci. 2013; 104:1508-14.2399248610.1111/cas.12268
    KagaCTakagiAKanoMKadoSKatoISakaiMet alLactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancerCancer Sci2013104150814765653223992486
    Open DOIBack to article
  33. 33Aragόn F, Carino S, Perdigόn G, de Moreno de LeBlanc A. Inhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431. J Immunotherapy. 2015; 38:185-96.10.1097/CJI.0000000000000079
    AragόnFCarinoSPerdigόnGde Moreno de LeBlancAInhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431J Immunotherapy2015381859625962107
    Open DOIBack to article
  34. 34Wagner SC, Riordan NH, Ichim TE, Szymanski J, Ma H, Perez JA, et al. Safety of targeting tumor endothelial cell antigens. J Trans Med. 2016; 14:1.
    WagnerSCRiordanNHIchimTESzymanskiJMaHPerezJAet alSafety of targeting tumor endothelial cell antigensJ Trans Med201614110.1186/s12967-016-0842-8483003427071457
    Back to article
  35. 35Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med. 1994; 180:35-42.800659310.1084/jem.180.1.35
    CouliePGBrichardVVan PelAWölfelTSchneiderJTraversariCet alA new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomasJ Exp Med1994180354221915748006593
    Open DOIBack to article
  36. 36Babu A, Templeton AK, Munshi A, Ramesh R. Nanoparticle-based drug delivery for therapy of lung cancer: progress and challenges. J Nanomater. 2013; 2013:14.
    BabuATempletonAKMunshiARameshRNanoparticle-based drug delivery for therapy of lung cancer:progress and challengesJ Nanomater201320131410.1155/2013/863951
    Back to article
  37. 37Pham VQ, Nguyen ST, Mai TT, Phan NK, Van Pham P. Breast cancer tumor growth is efficiently inhibited by dendritic cell transfusion in murine model. Biomed Res Ther. 2014; 1:85-92.
    PhamVQNguyenSTMaiTTPhanNKVanPhamPBreast cancer tumor growth is efficiently inhibited by dendritic cell transfusion in murine modelBiomed Res Ther20141859210.7603/s40730-014-0014-5
    Back to article
  38. 38Levine B, Vaz N. Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse. Int Arch Allergy Immunol. 1970; 39:156-7110.1159/000230343
    LevineBVazNEffect of combinations of inbred strain antigen and antigen dose on immune responsiveness and reagin production in the mouseInt Arch Allergy Immunol197039156714097264
    Open DOIBack to article
DOI: https://doi.org/10.5372/1905-7415.1004.494 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 327 - 334
Published on: Jan 31, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Cancer immunotherapy,
HSP,
Lactobacillus casei,
TNF-α,
tumor,
vaccine
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2017 Ruhollah Dorostkar, Mohammad Sadegh Hashemzadeh, Sajjad Jafari, Mahdi Tat, Majdedin Ghalavand, Mohammad Hossein Asghari, Milad Moloudizargari, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 10 (2016): Issue 4 (August 2016)Next article